MedPath

PROHANCE 279,3 mg/ml SOLUCION INYECTABLE EN JERINGA PRECARGADA

PROHANCE 279,3 mg/ml SOLUCION INYECTABLE EN JERINGA PRECARGADA

Commercialized
Register Number

64474

Prescription Type

Uso Hospitalario Y Centros De Diagnóstico Autorizados

Authorization Date

Dec 17, 2001

Dosage Form

SOLUCIÓN INYECTABLE

Route: VÍA INTRAVENOSA

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number64474
EMA Approved
No

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

GADOTERIDOLActive
Quantity: 279,3 mg
Name: GADOTERIDOL

ATC CLASSIFICATION (3)

V08C
V08CA
V08CA04

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.